Document Detail

Combination chemoradiotherapy in early hodgkin lymphoma.
MedLine Citation:
PMID:  24287066     Owner:  NLM     Status:  In-Data-Review    
Combination chemoradiotherapy achieves excellent results for the treatment of localized Hodgkin lymphoma. However, late toxic effects occur, mostly related to the radiotherapy administered after the standard adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) chemotherapy. The most serious sequelae are radiation-induced secondary cancers. Reducing radiotherapy has not yet prevented late malignancies. However, when radiotherapy was omitted, tumor control was inferior, with more relapses necessitating rescue treatment including high-dose chemotherapy with stem cell support. Early fluorodeoxyglucose positron emission tomography performed after a few cycles of ABVD is evaluated in several randomized trials to identify patients who might be safely treated with chemotherapy alone.
Marc P E André
Related Documents :
14596566 - Analyzing the traumatic impact of childhood visual impairment.
21594326 - Emetic control in breast cancer patients receiving iv cmf.
24565916 - Intra-muscular location in soft tissue sarcomas: impact on oncologic outcome.
23812226 - Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with ...
18327706 - A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induce...
3793086 - Diagnostic specificity of histologic features in lymph node biopsy specimens from patie...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hematology/oncology clinics of North America     Volume:  28     ISSN:  1558-1977     ISO Abbreviation:  Hematol. Oncol. Clin. North Am.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2013-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8709473     Medline TA:  Hematol Oncol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  33-47     Citation Subset:  IM    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
CHU Dinant Godinne, UCL Namur, 1 Avenue Thérasse, 5530 Yvoir, Belgium. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Brentuximab vedotin for the treatment of patients with hodgkin lymphoma.
Next Document:  Balancing risks and benefits of therapy for patients with favorable-risk limited-stage hodgkin lymph...